Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,224.1
19.5 (0.61%)

 

  • STI Straits Times Index
    3,224.1
    19.5 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.3
    -0.9 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,597.2
    -441.1 (-1.69%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,559.2
    -38.4 (-1.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,098.2
    -7.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,608.3
    -48.6 (-0.73%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,027.6M
  • Value: 618.1M
  • Rise: 175
  • Fall: 120
  • Unch: 456

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Tritech0.027+0.004
Koh Eco0.069+0.012
Raffles Edu0.069+0.010
Vividthree0.070+0.025
Boldtek0.114+0.005
GKE0.146+0.007
ThaiBev0.725+0.010
Zhongxin Fruit0.052+0.007
Progen0.054+0.003
Hatten Land0.062-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,595.0 -443.3
HSCEI 9,080.3 -179.1
Jakarta 6,610.7 -46.3
Nikkei 225 29,098.2 -7.8
SSE Comp 3,562.3 -35.3
Shanghai A 3,733.4 -37.1
Shanghai B 276.1 -1.2
KOSPI 3,025.5 -23.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DAXOR CORP DAXOR CORPORATION
Updated on 26 Oct 2021 (End of trading day)
Last (USD): 10.710 Change: +0.120 High: 10.711 Remarks: -
Change (%): +1.13 Low: 10.700
Open 10.711 Yesterday's Close 10.590000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,256 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.42667 Trailing EPS (USD) e -0.42667 NAV (USD) b 3.9217
PE a - Trailing PE f - Price / NAV b 2.7310
Dividend (USD) d - Cash In Hand (USD) g 0.1546 Issued & Paid-up Shares c 4,033,880
Dividend Yield (%) d - Price / Cash In Hand g 69.276 Treasury Shares h 1,282,653
Market Cap (M) 42.808 Enterprise Value (M) 42.361
Piotroski F Score 1 Exchange Code DXR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 53.27 Free Float (%) 47.6
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 04 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 27 Apr 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DAXOR CORP NYSE American 42.808 - - 2.7310 -
Industry Medical Specialties NYSE American 185.814 - 91.392 5.0839 -
Local Peer INFUSYSTEM HOLDINGS INC NYSE American 681.315 39.310 45.147 15.2413 -
Local Peer STEREOTAXIS INC NYSE American 438.105 - - 12.0147 -
Local Peer RETRACTABLE TECHNOLOGIES INC NYSE American 311.277 11.691 6.058 4.1835 -
Local Peer ALPHA PRO TECH NYSE American 93.657 3.458 4.478 1.5042 -
Local Peer VOLITIONRX LIMITED NYSE American 89.369 - - 3.3429 -
Local Peer ELECTROMED INC NYSE American 90.283 38.223 38.223 2.7851 -
Local Peer MILESTONE SCIENTIFIC INC NYSE American 68.289 - - 3.8598 -
Local Peer XTANT MEDICAL HLDGS INC NYSE American 21.531 - - 0.6354 -
Local Peer RA MEDICAL SYSTEMS INC NYSE American 21.510 - - 1.0116 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,332.514 37.542 27.842 6.4941 0.146
Global Peer ABBOTT LABORATORIES NYSE 227,151.427 50.783 31.461 - 1.193
Global Peer DANAHER CORP NYSE 219,325.119 62.486 38.330 5.4582 0.233
Global Peer MEDTRONIC PLC NYSE 166,947.731 46.297 42.995 3.2426 1.950
Global Peer INTUITIVE SURGICAL INC NASDAQ 124,476.136 117.364 73.689 10.9085 -
Global Peer STRYKER CORP NYSE 103,015.085 64.425 49.455 7.4541 0.860
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,923.143 88.564 49.865 14.2059 -
Global Peer BECTON DICKINSON & CO NYSE 70,749.257 92.241 37.935 2.9316 1.312
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,105.032 - 134.840 3.9584 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,466.084 95.339 76.206 74.2061 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), SILK ROAD MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH (HANGZHOU) INC (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PROCEPT BIOROBOTICS CORP (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), PEIJIA MEDICAL LIMITED (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CUE HEALTH INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), SIGHT SCIENCES INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), LEMAITRE VASCULAR INC (NASDAQ), SUPERMX (Bursa), ALPHATEC HLDGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), BIOVENTUS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), SISRAM MEDICAL LTD (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), INTERCURE LTD (NASDAQ), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), AXOGEN INC (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), VAPOTHERM INC (NYSE), SEASPINE HOLDINGS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PAVMED INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), LUCID DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), EARGO INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), CVRX INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), AROA BIOSURGERY LTD (ASX), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), QUOTIENT LTD (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), IMPEDIMED LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), EMVISION MEDICAL DEVICES LTD (ASX), UGHealthcare (SGX), Medtecs Intl (SGX), SOMNOMED LIMITED (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KELFRED HOLDINGS LTD (HKEx), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), MICRO-X LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), RGTBHD (Bursa), ENVVENO MED CORP (NASDAQ), SDI LTD (ASX), BIOLASE INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LENSAR INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), DIMERIX LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), BIOMERICA INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), NEOVASC INC (NASDAQ), CARDIEX LTD (ASX), NEUROMETRIX INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), COMPUMEDICS (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), RESHAPE LIFESCIENCES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NUTRIBAND INC (NASDAQ), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), YUNNAN ENERGY INTL CO LTD (HKEx), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ADVENTA (Bursa), Yunnan Energy (SGX), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ADHERIUM LIMITED (ASX), NUWELLIS INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), OVENTUS MEDICAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.180
-1.65 %
10 Days --0.390
-3.51 %
20 Days --0.790
-6.87 %
Medium Term Return 3 Months -+1.744
+19.45 %
6 Months -+0.860
+8.73 %
1 Year --3.679
-25.57 %
Long Term Return 2 Years -+1.360
+14.55 %
3 Years -+4.090
+61.78 %
5 Years 0.060+2.700
+34.46 %
Annualised Return Annualised --
+6.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.580 - 17.580 Change From 1 Year Low +2.130 % Change From 1 Year Low (%) +24.83
Change From 1 Year High -6.870 % Change From 1 Year High (%) -39.08
2 Years Range 7.850 - 24.076 Change From 2 Years Low +2.860 % Change From 2 Years Low (%) +36.43
Change From 2 Years High -13.366 % Change From 2 Years High (%) -55.52
5 Years Range 3.400 - 24.076 Change From 5 Years Low +7.310 % Change From 5 Years Low (%) +214.99
Change From 5 Years High -13.366 % Change From 5 Years High (%) -55.52
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Oct 2021 10.711 10.711 10.700 10.710 2,256 -
25 Oct 2021 10.590 10.590 10.590 10.590 - -
22 Oct 2021 10.760 10.880 10.590 10.590 2,418 -
21 Oct 2021 10.890 11.000 10.890 11.000 2,274 -
20 Oct 2021 11.255 11.314 10.890 10.890 1,944 -
19 Oct 2021 11.045 11.045 11.045 11.045 413 -
18 Oct 2021 11.250 11.250 11.250 11.250 - -
15 Oct 2021 11.110 11.250 11.080 11.250 2,192 -
14 Oct 2021 11.100 11.100 11.100 11.100 - -
13 Oct 2021 11.100 11.100 11.100 11.100 288 -
12 Oct 2021 11.225 11.225 11.225 11.225 - -
11 Oct 2021 11.225 11.225 11.225 11.225 283 -
08 Oct 2021 11.060 11.210 11.035 11.210 509 -
07 Oct 2021 11.110 11.110 11.100 11.100 380 -
06 Oct 2021 11.010 11.500 11.010 11.421 1,370 -
05 Oct 2021 11.250 11.740 11.010 11.010 2,167 -
04 Oct 2021 11.100 11.595 11.100 11.190 1,617 -
01 Oct 2021 11.750 11.750 11.250 11.250 494 -
30 Sep 2021 11.450 11.680 11.250 11.680 10,470 -
29 Sep 2021 10.960 11.500 10.960 11.500 2,173 -
28 Sep 2021 11.500 11.500 10.910 11.031 8,234 -
27 Sep 2021 11.500 11.500 11.500 11.500 294 -
Summary
Current 2 Weeks
(13 Oct 2021 to 26 Oct 2021)
11.100 11.314 10.590 10.710 11,785 -
Previous 2 Weeks
(29 Sep 2021 to 12 Oct 2021)
10.960 11.500 10.590 11.225 19,463 -
4 Weeks from
(31 Aug 2021 to 28 Sep 2021)
9.330 11.314 9.310 11.031 374,212 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.